tesofensine with tirzepatide Results — Weight Loss Timeline & What to Expect Tesofensine | TNS2330 triple monoamine

Importantly, 100% of participants receiving the 12 mg dose achieved at least 5% weight loss, while 91% achieved 10% or greater reduction, and 75% reached the clinically significant threshold of 15% weight loss

Well schedule regular follow-up appointments to monitor your progress, adjust your treatment plan as needed, and celebrate your victories along the way

When prescribed and monitored by trained healthcare professionals, like those here at Yorktown Health, semaglutide and tirzepatide are considered safe and effective

Identifying deficiencies early helps prevent prolonged shedding and supports healthy regrowth